 | • レポートコード：MRC2-11QY03912 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は上咽頭がんのグローバル市場について調査・分析したレポートです。種類別（手術、放射線、化学療法）市場規模、用途別（病院、診療所、がん治療・リハビリテーションセンター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別上咽頭がんの競争状況、市場シェア ・世界の上咽頭がん市場：種類別市場規模 2015年-2020年（手術、放射線、化学療法） ・世界の上咽頭がん市場：種類別市場規模予測 2021年-2026年（手術、放射線、化学療法） ・世界の上咽頭がん市場：用途別市場規模 2015年-2020年（病院、診療所、がん治療・リハビリテーションセンター） ・世界の上咽頭がん市場：用途別市場規模予測 2021年-2026年（病院、診療所、がん治療・リハビリテーションセンター） ・北米の上咽頭がん市場分析：米国、カナダ ・ヨーロッパの上咽頭がん市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの上咽頭がん市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の上咽頭がん市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの上咽頭がん市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche、Sanofi、Merck、Cyclacel Pharmaceuticals、Celgene、BioDiem ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Nasopharyngeal is a type of cancer which takes place in head or neck. It happens in nasopharynx, which is a upper part of the of the throat behind the nose. It is also called nasopharyngeal carcinoma (NPC). It has also been linked with Epstein-Barr virus.
Increasing geriatric population, rise in consumption of tobacco, increasing health awareness, changing lifestyle, are key driving factors for nasopharyngeal cancer treatment market.
Market Analysis and Insights: Global Nasopharyngeal Cancer Market
The global Nasopharyngeal Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Nasopharyngeal Cancer Scope and Market Size
Nasopharyngeal Cancer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nasopharyngeal Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Roche
Sanofi
Merck
Cyclacel Pharmaceuticals
Celgene
BioDiem
…
Market segment by Type, the product can be split into
Surgery
Radiation
Chemotherapy
Market segment by Application, split into
Hospitals
Clinics
Cancer Treatment and Rehabilitation Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Nasopharyngeal Cancer Revenue
1.4 Market by Type
1.4.1 Global Nasopharyngeal Cancer Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Surgery
1.4.3 Radiation
1.4.4 Chemotherapy
1.5 Market by Application
1.5.1 Global Nasopharyngeal Cancer Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Cancer Treatment and Rehabilitation Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Nasopharyngeal Cancer Market Perspective (2015-2026)
2.2 Global Nasopharyngeal Cancer Growth Trends by Regions
2.2.1 Nasopharyngeal Cancer Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Nasopharyngeal Cancer Historic Market Share by Regions (2015-2020)
2.2.3 Nasopharyngeal Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Nasopharyngeal Cancer Market Growth Strategy
2.3.6 Primary Interviews with Key Nasopharyngeal Cancer Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Nasopharyngeal Cancer Players by Market Size
3.1.1 Global Top Nasopharyngeal Cancer Players by Revenue (2015-2020)
3.1.2 Global Nasopharyngeal Cancer Revenue Market Share by Players (2015-2020)
3.1.3 Global Nasopharyngeal Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Nasopharyngeal Cancer Market Concentration Ratio
3.2.1 Global Nasopharyngeal Cancer Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Nasopharyngeal Cancer Revenue in 2019
3.3 Nasopharyngeal Cancer Key Players Head office and Area Served
3.4 Key Players Nasopharyngeal Cancer Product Solution and Service
3.5 Date of Enter into Nasopharyngeal Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Nasopharyngeal Cancer Historic Market Size by Type (2015-2020)
4.2 Global Nasopharyngeal Cancer Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Nasopharyngeal Cancer Market Size by Application (2015-2020)
5.2 Global Nasopharyngeal Cancer Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Nasopharyngeal Cancer Market Size (2015-2020)
6.2 Nasopharyngeal Cancer Key Players in North America (2019-2020)
6.3 North America Nasopharyngeal Cancer Market Size by Type (2015-2020)
6.4 North America Nasopharyngeal Cancer Market Size by Application (2015-2020)
7 Europe
7.1 Europe Nasopharyngeal Cancer Market Size (2015-2020)
7.2 Nasopharyngeal Cancer Key Players in Europe (2019-2020)
7.3 Europe Nasopharyngeal Cancer Market Size by Type (2015-2020)
7.4 Europe Nasopharyngeal Cancer Market Size by Application (2015-2020)
8 China
8.1 China Nasopharyngeal Cancer Market Size (2015-2020)
8.2 Nasopharyngeal Cancer Key Players in China (2019-2020)
8.3 China Nasopharyngeal Cancer Market Size by Type (2015-2020)
8.4 China Nasopharyngeal Cancer Market Size by Application (2015-2020)
9 Japan
9.1 Japan Nasopharyngeal Cancer Market Size (2015-2020)
9.2 Nasopharyngeal Cancer Key Players in Japan (2019-2020)
9.3 Japan Nasopharyngeal Cancer Market Size by Type (2015-2020)
9.4 Japan Nasopharyngeal Cancer Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Nasopharyngeal Cancer Market Size (2015-2020)
10.2 Nasopharyngeal Cancer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Nasopharyngeal Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia Nasopharyngeal Cancer Market Size by Application (2015-2020)
11 India
11.1 India Nasopharyngeal Cancer Market Size (2015-2020)
11.2 Nasopharyngeal Cancer Key Players in India (2019-2020)
11.3 India Nasopharyngeal Cancer Market Size by Type (2015-2020)
11.4 India Nasopharyngeal Cancer Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Nasopharyngeal Cancer Market Size (2015-2020)
12.2 Nasopharyngeal Cancer Key Players in Central & South America (2019-2020)
12.3 Central & South America Nasopharyngeal Cancer Market Size by Type (2015-2020)
12.4 Central & South America Nasopharyngeal Cancer Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview
13.1.3 Roche Nasopharyngeal Cancer Introduction
13.1.4 Roche Revenue in Nasopharyngeal Cancer Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Sanofi
13.2.1 Sanofi Company Details
13.2.2 Sanofi Business Overview
13.2.3 Sanofi Nasopharyngeal Cancer Introduction
13.2.4 Sanofi Revenue in Nasopharyngeal Cancer Business (2015-2020)
13.2.5 Sanofi Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Nasopharyngeal Cancer Introduction
13.3.4 Merck Revenue in Nasopharyngeal Cancer Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Cyclacel Pharmaceuticals
13.4.1 Cyclacel Pharmaceuticals Company Details
13.4.2 Cyclacel Pharmaceuticals Business Overview
13.4.3 Cyclacel Pharmaceuticals Nasopharyngeal Cancer Introduction
13.4.4 Cyclacel Pharmaceuticals Revenue in Nasopharyngeal Cancer Business (2015-2020)
13.4.5 Cyclacel Pharmaceuticals Recent Development
13.5 Celgene
13.5.1 Celgene Company Details
13.5.2 Celgene Business Overview
13.5.3 Celgene Nasopharyngeal Cancer Introduction
13.5.4 Celgene Revenue in Nasopharyngeal Cancer Business (2015-2020)
13.5.5 Celgene Recent Development
13.6 BioDiem
13.6.1 BioDiem Company Details
13.6.2 BioDiem Business Overview
13.6.3 BioDiem Nasopharyngeal Cancer Introduction
13.6.4 BioDiem Revenue in Nasopharyngeal Cancer Business (2015-2020)
13.6.5 BioDiem Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Nasopharyngeal Cancer Key Market Segments
Table 2. Key Players Covered: Ranking by Nasopharyngeal Cancer Revenue
Table 3. Ranking of Global Top Nasopharyngeal Cancer Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Nasopharyngeal Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Surgery
Table 6. Key Players of Radiation
Table 7. Key Players of Chemotherapy
Table 8. Global Nasopharyngeal Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Nasopharyngeal Cancer Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Nasopharyngeal Cancer Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Nasopharyngeal Cancer Market Share by Regions (2015-2020)
Table 12. Global Nasopharyngeal Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Nasopharyngeal Cancer Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Nasopharyngeal Cancer Market Growth Strategy
Table 18. Main Points Interviewed from Key Nasopharyngeal Cancer Players
Table 19. Global Nasopharyngeal Cancer Revenue by Players (2015-2020) (Million US$)
Table 20. Global Nasopharyngeal Cancer Market Share by Players (2015-2020)
Table 21. Global Top Nasopharyngeal Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nasopharyngeal Cancer as of 2019)
Table 22. Global Nasopharyngeal Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Nasopharyngeal Cancer Product Solution and Service
Table 25. Date of Enter into Nasopharyngeal Cancer Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Nasopharyngeal Cancer Market Size by Type (2015-2020) (Million US$)
Table 28. Global Nasopharyngeal Cancer Market Size Share by Type (2015-2020)
Table 29. Global Nasopharyngeal Cancer Revenue Market Share by Type (2021-2026)
Table 30. Global Nasopharyngeal Cancer Market Size Share by Application (2015-2020)
Table 31. Global Nasopharyngeal Cancer Market Size by Application (2015-2020) (Million US$)
Table 32. Global Nasopharyngeal Cancer Market Size Share by Application (2021-2026)
Table 33. North America Key Players Nasopharyngeal Cancer Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Nasopharyngeal Cancer Market Share (2019-2020)
Table 35. North America Nasopharyngeal Cancer Market Size by Type (2015-2020) (Million US$)
Table 36. North America Nasopharyngeal Cancer Market Share by Type (2015-2020)
Table 37. North America Nasopharyngeal Cancer Market Size by Application (2015-2020) (Million US$)
Table 38. North America Nasopharyngeal Cancer Market Share by Application (2015-2020)
Table 39. Europe Key Players Nasopharyngeal Cancer Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Nasopharyngeal Cancer Market Share (2019-2020)
Table 41. Europe Nasopharyngeal Cancer Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Nasopharyngeal Cancer Market Share by Type (2015-2020)
Table 43. Europe Nasopharyngeal Cancer Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Nasopharyngeal Cancer Market Share by Application (2015-2020)
Table 45. China Key Players Nasopharyngeal Cancer Revenue (2019-2020) (Million US$)
Table 46. China Key Players Nasopharyngeal Cancer Market Share (2019-2020)
Table 47. China Nasopharyngeal Cancer Market Size by Type (2015-2020) (Million US$)
Table 48. China Nasopharyngeal Cancer Market Share by Type (2015-2020)
Table 49. China Nasopharyngeal Cancer Market Size by Application (2015-2020) (Million US$)
Table 50. China Nasopharyngeal Cancer Market Share by Application (2015-2020)
Table 51. Japan Key Players Nasopharyngeal Cancer Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Nasopharyngeal Cancer Market Share (2019-2020)
Table 53. Japan Nasopharyngeal Cancer Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Nasopharyngeal Cancer Market Share by Type (2015-2020)
Table 55. Japan Nasopharyngeal Cancer Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Nasopharyngeal Cancer Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Nasopharyngeal Cancer Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Nasopharyngeal Cancer Market Share (2019-2020)
Table 59. Southeast Asia Nasopharyngeal Cancer Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Nasopharyngeal Cancer Market Share by Type (2015-2020)
Table 61. Southeast Asia Nasopharyngeal Cancer Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Nasopharyngeal Cancer Market Share by Application (2015-2020)
Table 63. India Key Players Nasopharyngeal Cancer Revenue (2019-2020) (Million US$)
Table 64. India Key Players Nasopharyngeal Cancer Market Share (2019-2020)
Table 65. India Nasopharyngeal Cancer Market Size by Type (2015-2020) (Million US$)
Table 66. India Nasopharyngeal Cancer Market Share by Type (2015-2020)
Table 67. India Nasopharyngeal Cancer Market Size by Application (2015-2020) (Million US$)
Table 68. India Nasopharyngeal Cancer Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Nasopharyngeal Cancer Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Nasopharyngeal Cancer Market Share (2019-2020)
Table 71. Central & South America Nasopharyngeal Cancer Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Nasopharyngeal Cancer Market Share by Type (2015-2020)
Table 73. Central & South America Nasopharyngeal Cancer Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Nasopharyngeal Cancer Market Share by Application (2015-2020)
Table 75. Roche Company Details
Table 76. Roche Business Overview
Table 77. Roche Product
Table 78. Roche Revenue in Nasopharyngeal Cancer Business (2015-2020) (Million US$)
Table 79. Roche Recent Development
Table 80. Sanofi Company Details
Table 81. Sanofi Business Overview
Table 82. Sanofi Product
Table 83. Sanofi Revenue in Nasopharyngeal Cancer Business (2015-2020) (Million US$)
Table 84. Sanofi Recent Development
Table 85. Merck Company Details
Table 86. Merck Business Overview
Table 87. Merck Product
Table 88. Merck Revenue in Nasopharyngeal Cancer Business (2015-2020) (Million US$)
Table 89. Merck Recent Development
Table 90. Cyclacel Pharmaceuticals Company Details
Table 91. Cyclacel Pharmaceuticals Business Overview
Table 92. Cyclacel Pharmaceuticals Product
Table 93. Cyclacel Pharmaceuticals Revenue in Nasopharyngeal Cancer Business (2015-2020) (Million US$)
Table 94. Cyclacel Pharmaceuticals Recent Development
Table 95. Celgene Company Details
Table 96. Celgene Business Overview
Table 97. Celgene Product
Table 98. Celgene Revenue in Nasopharyngeal Cancer Business (2015-2020) (Million US$)
Table 99. Celgene Recent Development
Table 100. BioDiem Company Details
Table 101. BioDiem Business Overview
Table 102. BioDiem Product
Table 103. BioDiem Revenue in Nasopharyngeal Cancer Business (2015-2020) (Million US$)
Table 104. BioDiem Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nasopharyngeal Cancer Market Share by Type: 2020 VS 2026
Figure 2. Surgery Features
Figure 3. Radiation Features
Figure 4. Chemotherapy Features
Figure 5. Global Nasopharyngeal Cancer Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Cancer Treatment and Rehabilitation Centers Case Studies
Figure 9. Nasopharyngeal Cancer Report Years Considered
Figure 10. Global Nasopharyngeal Cancer Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Nasopharyngeal Cancer Market Share by Regions: 2020 VS 2026
Figure 12. Global Nasopharyngeal Cancer Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Nasopharyngeal Cancer Market Share by Players in 2019
Figure 15. Global Top Nasopharyngeal Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nasopharyngeal Cancer as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Nasopharyngeal Cancer Revenue in 2019
Figure 17. North America Nasopharyngeal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Nasopharyngeal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Nasopharyngeal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Nasopharyngeal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Nasopharyngeal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Nasopharyngeal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Nasopharyngeal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
非血液がん治療の世界市場（～2026年） Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient. North America has the huge number of population suffering fr…- 転移性がん治療の世界市場（～2026年） Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…
- 甲状腺がん治療の世界市場（～2026年） Market Analysis and Insights: Global Thyroid Cancer Treatment Market The global Thyroid Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Thyroid Cancer Treatment Scope and Market Size Thyroid Cancer Tre…
- 小細胞肺がん治療の世界市場（～2026年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Small Cell Lung Cancer Treatment Scope and Market…
- 転移性大腸癌手術の世界市場（～2026年） Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…